首页> 外文会议>International Conference on Advanced Composite Materials and Manufacturing Engineering >Analysis on The Application Prospect of Staghorn Glue in Uterine Dysplasia
【24h】

Analysis on The Application Prospect of Staghorn Glue in Uterine Dysplasia

机译:子宫发育不良粘液胶的应用前景分析

获取原文

摘要

To explore the application prospect of Chinese medicine deerhorn glue in uterine dysplasia.Methods:The association rule analysis and factor analysis of the included standard Chinese medicine were conducted using the journal literature collected by cnki as the data source,and the tools of Excel 2013,SPSS Modeler 14.1 and SPSS Statistics 19.0.Results:Among the 106 prescriptions included in the inclusion criteria,38 high-frequency drugs with the frequency of >10 were used,among which angelica sinensis (84 times,79.25%),rehmannia rehmannii (73 times,68.87%),dota cuscuta (72 times,67.92%) and medlar fruit (46 times,43.40%) were the most common.The drugs for the treatment of uterine dysplasia were mainly wen (691 times,54.50%),ping (310 times,24.25%),wuwei (937 times,42.80%),guijing (977 times,30.09%) and kidney (771 times,23.74%).The most commonly used drugs were tonic drugs for deficiency (803 times,63.28%) and drugs for activating blood circulation and removing blood stasis (169 times,13.32%).In association rule analysis,14 combinations with the highest association intensity were found,and 9 common factors were extracted from factor analysis.Conclusion:Treatment of uterine dysplasia more to make up for virtual medicine is given priority to,such as Chinese angelica,rehmannia glutinosa,etc.),the clinical use of compatibility of promoting blood circulation to remove blood stasis pill (herba leonuri,salvia miltiorrhiza),temperature in medicine,medicinal choosing GanWen,liver and kidney by the combination of drugs such as medicine,antler glue from sexual flavour to the efficacy of application,etc.,in accordance with its statistical results,it has great development prospects,treatment can be further explored.
机译:探讨中药Deerhorn胶水在子宫发育中的应用前景。方法:使用CNKI收集的杂志作为数据源的杂志进行了录取的标准中医的关联规则分析和因子分析,以及Excel 2013的工具, SPSS Modeler 14.1和SPSS统计数据19.0.结果:在纳入标准中包含的106个处方中,使用了38个具有> 10次频率的高频药物,其中Angelica Sinensis(84次,79.25%),Rehmannia Rehmannii(73时代,68.87%),Dota Cuscuta(72次,67.92%)和枸杞子(46次,43.40%)是最常见的。用于治疗子宫发育不良的药物主要是温(691次,54.50%),ping (310次,24.25%),武威(937次,42.80%),桂晶(977次,30.09%)和肾脏(771次,23.74%)。最常用的药物是缺乏滋补药物(803次,63.28 %)和用于激活血液循环和去除血瘀的药物(169次,13次。 32%)。在结合规则分析中,发现了14种具有最高关联强度的组合,并从因子分析中提取了9种常见因素。结论:uterine发育不良的治疗更为弥补虚拟药物,例如中国人Angelica,Rehmannia glutinosa等。),促进血液循环的临床用途去除血瘀丸(草本莱昂,丹参,丹参),医学温度,药用选择甘温,肝肾,肝肾,肝肾等药物的组合,鹿茸从性感到效果的应用等,按照其统计结果,它具有很大的发展前景,可以进一步探索治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号